Sangamo Therapeutics
SGMO
#10562
Rank
โ‚น2.91 B
Marketcap
โ‚น7.04
Share price
0.00%
Change (1 day)
-85.21%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -โ‚น9.92 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚น34.55 Million. In 2025 the company made an earning of -โ‚น10.28 Billion a decrease over its 2024 earnings that were of -โ‚น9.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น9.92 Billion-3.5%
2025 -โ‚น10.28 Billion9.71%
2024 -โ‚น9.37 Billion-17.27%
2023 -โ‚น11.33 Billion-40.88%
2022 -โ‚น19.16 Billion9.79%
2021 -โ‚น17.45 Billion41.52%
2020 -โ‚น12.33 Billion23.17%
2019 -โ‚น10.01 Billion36.33%
2018 -โ‚น7.35 Billion36.89%
2017 -โ‚น5.37 Billion-22.32%
2016 -โ‚น6.91 Billion54.86%
2015 -โ‚น4.46 Billion75.62%
2014 -โ‚น2.54 Billion0.13%
2013 -โ‚น2.54 Billion
2011 -โ‚น3.41 Billion43.66%
2010 -โ‚น2.38 Billion28.52%
2009 -โ‚น1.85 Billion-23.55%
2008 -โ‚น2.42 Billion2.45%
2007 -โ‚น2.36 Billion19.5%
2006 -โ‚น1.98 Billion50.78%
2005 -โ‚น1.31 Billion75%
2004 -โ‚น0.75 Billion-33.25%
2003 -โ‚น1.12 Billion-62.27%
2002 -โ‚น2.97 Billion102.82%
2001 -โ‚น1.47 Billion23.21%
2000 -โ‚น1.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.471 T-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น864.64 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น154.43 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น240.45 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น1.020 T-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.251 T-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น82.75 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.69 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA